Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study.
about
Pharmacological treatment of anxiety disorders: current treatments and future directionsCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersThe evidence-based pharmacotherapy of social anxiety disorderEfficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: an analysis of pooled data from three 8-week placebo-controlled studies.Review of the use of mirtazapine in the treatment of depression.Psychometric validation study of the liebowitz social anxiety scale - self-reported version for Brazilian Portuguese.Optimal treatment of social phobia: systematic review and meta-analysis.A review of therapeutic uses of mirtazapine in psychiatric and medical conditions.Update on the efficacy of pharmacotherapy for social anxiety disorder: a meta-analysis.New research on anxiety disorders in the elderly and an update on evidence-based treatments.Generalized social anxiety disorder: A still-neglected anxiety disorder 3 decades since Liebowitz's review.Don't ask, don't tell: a systematic review of the extent to which participant characteristics are reported in social anxiety treatment studies.A meta-analysis of pharmacotherapy for social anxiety disorder: an examination of efficacy, moderators, and mediators.Duloxetine in treating generalized anxiety disorder in adults: A meta-analysis of published randomized, double-blind, placebo-controlled trials.Pharmacotherapy for social anxiety disorder (SAnD).Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology.
P2860
Q26851461-04D0708E-99AE-4EF8-89EF-E2C11CBAACF6Q27009995-BB517C28-E54C-4F76-A4F6-0B16D12FC5C7Q28262456-23223E89-9CF2-42F0-9AB3-30D40E7C02BAQ34092254-CB0A031C-CDFC-48BD-A21A-B70BCAA1537EQ34190102-F9515502-309E-463A-AE80-9EBD94070C66Q34906561-DEA32784-F4B4-41B4-9A38-4C48A497E4D1Q35997293-FEFDFFF5-E399-4648-8906-069145520EFBQ37533880-4BE88C34-4DEA-40EE-91E5-6B4662658348Q38256876-8008FFAE-9288-4A4E-AD0F-42397359C372Q38484380-A759F747-991B-4DCD-8EBE-2C4159771549Q38539809-E90AFC5C-74A1-4DCF-9B9A-88D3E9585D2BQ38686261-E3F956E3-1412-4952-925B-6443D1B47676Q38767369-F5F9F002-1A6B-4F02-B068-50293456AA51Q40665191-FF918C24-D813-49D6-8ABA-3467DD7E137EQ47593921-9A406A83-BC29-4CC5-80A1-30D8B68B39C2Q53091817-97C102CD-48E7-4FA1-B1DF-0A398B9F221B
P2860
Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mirtazapine in generalized soc ...... ind, placebo-controlled study.
@ast
Mirtazapine in generalized soc ...... ind, placebo-controlled study.
@en
Mirtazapine in generalized soc ...... ind, placebo-controlled study.
@nl
type
label
Mirtazapine in generalized soc ...... ind, placebo-controlled study.
@ast
Mirtazapine in generalized soc ...... ind, placebo-controlled study.
@en
Mirtazapine in generalized soc ...... ind, placebo-controlled study.
@nl
prefLabel
Mirtazapine in generalized soc ...... ind, placebo-controlled study.
@ast
Mirtazapine in generalized soc ...... ind, placebo-controlled study.
@en
Mirtazapine in generalized soc ...... ind, placebo-controlled study.
@nl
P2093
P1476
Mirtazapine in generalized soc ...... ind, placebo-controlled study.
@en
P2093
Damiaan A J P Denys
Harold J G M Van Megen
Herman G M Westenberg
Jantien Frederieke Van Veen
Sara I J Schutters
P304
P356
10.1097/YIC.0B013E32833A4D71
P577
2010-09-01T00:00:00Z